Quantcast
Last updated on April 24, 2014 at 5:30 EDT

Latest Adam Brufsky Stories

2011-07-18 14:12:45

The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed. Based on these study results, lead researcher Adam Brufsky, M.D., Ph.D., said, "We clearly now know that these women should get trastuzumab and potentially chemotherapy, even if cancer spreads to the brain." "Women with HER2-positive breast cancer have a reasonable chance of living a long time...